7th Jun 2021 10:50
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | UDG HEALTHCARE PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 04 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
5,314,224 | 2.11% | 121,547 | 0.05% | ||
(2) | Derivatives (other than options): | ||||
82,054 | 0.03% | 4,850,251 | 1.93% | ||
(3) | Options and agreements to | ||||
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
TOTAL: | |||||
5,396,278 | 2.14% | 4,971,798 | 1.97% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1,778 | 10.6035 GBP |
Purchase | 2,579 | 10.6220 GBP |
Purchase | 2,599 | 10.6000 GBP |
Purchase | 2,691 | 10.6329 GBP |
Purchase | 3,546 | 10.6314 GBP |
Purchase | 3,952 | 10.6211 GBP |
Purchase | 4,219 | 10.6367 GBP |
Purchase | 7,689 | 10.6400 GBP |
Purchase | 30,000 | 10.6331 GBP |
Purchase | 81,442 | 10.6152 GBP |
Sale | 329 | 10.6100 GBP |
Sale | 433 | 10.6353 GBP |
Sale | 787 | 10.6274 GBP |
Sale | 851 | 10.6105 GBP |
Sale | 1,261 | 10.6187 GBP |
Sale | 1,282 | 10.6351 GBP |
Sale | 1,350 | 10.6254 GBP |
Sale | 2,140 | 10.6300 GBP |
Sale | 2,610 | 10.6400 GBP |
Sale | 3,966 | 10.6017 GBP |
Sale | 4,033 | 10.6364 GBP |
Sale | 4,594 | 10.6337 GBP |
Sale | 5,000 | 10.6200 GBP |
Sale | 5,231 | 10.6315 GBP |
Sale | 9,276 | 10.6206 GBP |
Sale | 39,730 | 10.6305 GBP |
Sale | 50,000 | 10.6239 GBP |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
|
| unit |
SWAP | Long | 7,595 | 10.6306 GBP |
SWAP | Long | 8,173 | 10.6302 GBP |
SWAP | Long | 8,299 | 10.6288 GBP |
SWAP | Long | 9,271 | 10.6254 GBP |
SWAP | Long | 16,599 | 10.6200 GBP |
CFD | Short | 2,579 | 10.6220 GBP |
SWAP | Short | 9,651 | 10.6110 GBP |
SWAP | Short | 20,143 | 10.6123 GBP |
SWAP | Short | 23,745 | 10.6183 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 7 Jun 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210607005365/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L